医学博士陈莉莉，继续担任董事长，公司业绩下降超八成

Group 1 - The core point of the article is the leadership changes at Mingde Biological, with Chen Lili elected as the new chairperson and general manager, and Wang Ying appointed as the vice chairperson and vice general manager [1][7] - Chen Lili has a strong academic background, holding a doctorate from Heidelberg University and postdoctoral experience at Boston University Medical Center [2][4] - The company was founded in 2008 by Chen Lili and Wang Ying, and it successfully went public on the Shenzhen Stock Exchange in 2018 [4][8] Group 2 - As of the third quarter of 2025, Mingde Biological reported a revenue of 227 million yuan, a year-on-year increase of 0.53%, while the net profit attributable to shareholders decreased by 83.30% to 13.52 million yuan [8] - The company's stock closed at 18.78 yuan per share on November 5, with a market capitalization of approximately 4.367 billion yuan [10]